1.
The Effect of Arsenic Trioxide on Imatinib-Resistant Cell Lines K562R and KBM5R
三氧化二砷对伊马替尼耐药细胞株K562R和KBM5R作用机制的研究
2.
Detection of the BCR-ABL Fusion Gene Levels in Chronic Myeloid Leukemia Patients by Real-time Quantitative RT-PCR and Mutation Analysis in the Imatinib Resistant Patients
慢性髓细胞白血病患者bcr/abl的定量检测及伊马替尼耐药患者基因突变分析
3.
Advances in drug resistance of imatinib mesylate
甲磺酸伊马替尼耐药机制及其逆转研究进展
4.
The Establishment of Bortezomib Resistant Myeloma Cell Line and Study of Its Drug Resistance Mechanism
硼替佐米耐药骨髓瘤细胞株的建立及其耐药机制研究
5.
Efficacy and safety evaluation of imatinib in treatment of patients with chronic myeloid leukemia
伊马替尼治疗慢性粒细胞白血病疗效分析
6.
Lapatinib in Combination with Bortezomib Inhibits Breast Cancer Cells Growth and the Activity of Bortezomib to Lapatinib-resistant Breast Cancer Cell
拉帕替尼联合硼替佐米抑制乳腺癌细胞生长及硼替佐米对拉帕替尼耐药细胞的活性的研究
7.
The Study on the Mechanism of the Gastrointestinal Stromal Tumor Patients with Acquired Resistance to Imatinib Therapy
甲磺酸伊马替尼治疗胃肠道间质瘤与耐药机制的研究
8.
Proteasome Inhibitor Bortezomib Sensitize the Multidrug Resistant K562/DNR Cells to Conventional Chemotherapeutic Drugs;
硼替佐米增加耐药白血病细胞株K562/DNR对化疗药物敏感性的研究
9.
The Anti-tumoral Effect of Curcumin Combined with Imatinib on Chronic Myelogenous Leukemia Cell Lines in Vitro;
姜黄素与伊马替尼体外协同抗慢性粒细胞白血病的分子机制研究
10.
Molecular Cytogenetic Study in Chronic Myeloid Leukaemia Treated with Imatinib;
伊马替尼治疗慢性粒细胞白血病的分子遗传学研究
11.
Clinical Efficacy of Imatinib Meylate in Treatment of Patients with Chronic Myeloid Leukemia in Advanced Phase;
甲磺酸伊马替尼治疗进展期慢性粒细胞白血病的临床疗效观察
12.
Effects of Mesylate Imatinib on the Expression of SHIP Gene and Apoptosis of K562 Cells;
伊马替尼对K562细胞内SHIP基因表达的影响及其促凋亡作用
13.
Effect on SHIP-2 Gene of Gleevec in K562 Cells and It's Significance
甲磺酸伊马替尼对K562细胞SHIP-2基因表达的影响及意义
14.
Clinical observation of imatinib in treatment of patients with chronic myeloid leukemia
甲磺酸伊马替尼治疗慢性粒细胞白血病的临床观察
15.
Expression of hOCT1 in Patients with Chronic Myelogeneous Leukemia Treated by Imatinib Mesylate
服用伊马替尼慢性粒细胞白血病患者hOCT1表达的变化
16.
Effect of proteasome inhibitor combined with imatinib on expression of livin mRNA in K562 cells
蛋白酶体抑制剂联合伊马替尼对K562细胞livin基因表达的影响
17.
Efficacy and safety evaluation of imatinib in the treatment of 122 cases of chronic myeloid leukemia
甲磺酸伊马替尼治疗慢性粒细胞白血病122例疗效评价
18.
Experimental Study of MDR-reversing Effect of Sorafenib on Human Hepatocellular Carcinoma HepG2/GEM
索拉非尼逆转肝癌细胞株HepG2/GEM耐药作用的实验研究